{"id":24372,"date":"2023-03-27T08:10:18","date_gmt":"2023-03-27T08:10:18","guid":{"rendered":"https:\/\/rechemco.to\/?post_type=product&#038;p=24372"},"modified":"2026-08-03T03:35:53","modified_gmt":"2026-08-03T03:35:53","slug":"nervigesic-pregabalin-150-eu","status":"publish","type":"product","link":"https:\/\/rechemco.to\/ro\/nervigesic-pregabalin-150-eu\/","title":{"rendered":"Nervigesic Pregabalin 150 EU"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><strong>Pregabalin: O revizuire cuprinz\u0103toare<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalina este un medicament eliberat pe baz\u0103 de prescrip\u021bie medical\u0103 cu o serie de aplica\u021bii medicale importante. Este un gabapentinoid sau un analog al neurotransmi\u021b\u0103torului acid gama-aminobutiric (GABA). \u00cen ciuda acestui fapt, pregabalina nu se leag\u0103 direct de receptorii GABA. \u00cen schimb, se leag\u0103 puternic de subunitatea \u03b12\u03b4 (alfa2delta) a canalelor de calciu portate de tensiune din sistemul nervos central (SNC). Acest medicament, cunoscut \u00een comer\u021b sub numele de Lyrica, printre alte denumiri, a fost sintetizat pentru prima dat\u0103 la \u00eenceputul anilor 1990 de c\u0103tre compania farmaceutic\u0103 Pfizer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Farmacologia Pregabalinului<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mecanismul de ac\u021biune al Pregabalinei este destul de complex. Acesta moduleaz\u0103 canalele de calciu \u0219i reduce eliberarea mai multor neurotransmi\u021b\u0103tori, inclusiv a glutamatului, norepinefrinei, substan\u021bei P \u0219i a peptidei legate de gena calcitoninei (CGRP). Prin modificarea func\u021bion\u0103rii acestor neurotransmi\u021b\u0103tori, atenueaz\u0103 efectele lor asupra semnalelor nervoase, ceea ce duce la ameliorarea simptomelor \u00een mai multe afec\u021biuni neurologice.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Efectele Pregabalinei asupra neurotransmi\u021b\u0103torului glutamat sunt deosebit de importante, deoarece glutamatul este principalul neurotransmi\u021b\u0103tor excitator din sistemul nervos. Cantit\u0103\u021bile excesive de glutamat pot duce la supraexcitarea celulelor nervoase, un factor care contribuie la afec\u021biuni precum epilepsia \u0219i durerea neuropatic\u0103. Prin reducerea eliber\u0103rii de glutamat, pregabalina poate ajuta la controlul acestor afec\u021biuni.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cen plus, pregabalina nu se leag\u0103 de proteinele plasmatice, ceea ce face mai pu\u021bin probabil\u0103 interac\u021biunea cu alte medicamente. Biodisponibilitatea sa este ridicat\u0103 (mai mare de 90%) \u0219i nu variaz\u0103 \u00een func\u021bie de doz\u0103, ceea ce \u00eenseamn\u0103 c\u0103 este aproape complet absorbit\u0103 dup\u0103 ingestia oral\u0103. Atinge concentra\u021bia maxim\u0103 \u00een s\u00e2nge \u00een decurs de o or\u0103 dup\u0103 ingestie \u0219i este eliminat din circula\u021bia sistemic\u0103 \u00een principal prin excre\u021bie renal\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Utiliz\u0103ri clinice ale Pregabalinului<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalina are utiliz\u0103ri multiple \u00een domeniul medicinei datorit\u0103 capacit\u0103\u021bii sale de a modula sistemul nervos. Principalele indica\u021bii pentru utilizarea sa includ:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Durerea neuropatic\u0103<\/strong>: Pregabalina este adesea utilizat\u0103 pentru a gestiona durerea neuropat\u0103, care apare din cauza afect\u0103rii sistemului nervos. Printre afec\u021biunile care pot provoca acest tip de durere se num\u0103r\u0103 diabetul (neuropatie diabetic\u0103), infec\u021bia cu herpes zoster (nevralgie postherpetic\u0103) \u0219i leziuni ale m\u0103duvei spin\u0103rii.<\/li>\n\n\n\n<li><strong>Epilepsie<\/strong>: Pregabalina se utilizeaz\u0103 ca terapie adjuvant\u0103 la adul\u021bii cu convulsii par\u021biale, cu sau f\u0103r\u0103 generalizare secundar\u0103. Prin modularea eliber\u0103rii de glutamat, ajut\u0103 la controlul convulsiilor la ace\u0219ti pacien\u021bi.<\/li>\n\n\n\n<li><strong>Fibromialgie<\/strong>: Este, de asemenea, eficient \u00een tratarea fibromialgiei, o afec\u021biune caracterizat\u0103 prin dureri cronice generalizate \u0219i un r\u0103spuns crescut la durere la presiune.<\/li>\n\n\n\n<li><strong>Tulburarea de anxietate generalizat\u0103 (GAD)<\/strong>: \u00cen Uniunea European\u0103, pregabalina este aprobat\u0103 pentru tratamentul tulbur\u0103rii de anxietate generalizat\u0103. Efectul s\u0103u calmant asupra sistemului nervos ajut\u0103 la reducerea simptomelor acestei afec\u021biuni.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dozare \u0219i administrare<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dozajul de pregabalin\u0103 variaz\u0103 \u00een func\u021bie de afec\u021biunea pe care este utilizat\u0103 pentru a o trata, de func\u021bia renal\u0103 a pacientului \u0219i de r\u0103spunsul acestuia la tratament.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pentru durerea neuropat\u0103 asociat\u0103 cu neuropatia periferic\u0103 diabetic\u0103, doza ini\u021bial\u0103 este de obicei de 50 mg de trei ori pe zi (150 mg\/zi), care poate fi crescut\u0103 p\u00e2n\u0103 la o doz\u0103 maxim\u0103 de 300 mg\/zi \u00een decurs de 1 s\u0103pt\u0103m\u00e2n\u0103, pe baza eficacit\u0103\u021bii \u0219i tolerabilit\u0103\u021bii.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pentru nevralgia postherpetic\u0103, doza ini\u021bial\u0103 recomandat\u0103 este de 75 mg de dou\u0103 ori pe zi sau 50 mg de trei ori pe zi (150 mg\/zi). \u00cen func\u021bie de r\u0103spunsul individual al pacientului \u0219i de tolerabilitate, doza poate fi crescut\u0103 p\u00e2n\u0103 la o doz\u0103 maxim\u0103 de 300 mg\/zi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cen epilepsie, doza ini\u021bial\u0103 este de obicei de 75 mg de dou\u0103 ori pe zi sau 50 mg de trei ori pe zi, care poate fi crescut\u0103 la 150 mg de dou\u0103 ori pe zi sau 100 mg de trei ori pe zi \u00een decurs de o s\u0103pt\u0103m\u00e2n\u0103, pe baza eficacit\u0103\u021bii \u0219i toleran\u021bei.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cen tratarea fibromialgiei, doza ini\u021bial\u0103 tipic\u0103 este de 75 mg de dou\u0103 ori pe zi, care poate fi crescut\u0103 p\u00e2n\u0103 la o doz\u0103 \u021bint\u0103 de 300-450 mg\/zi. Pentru tratarea tulbur\u0103rii de anxietate generalizat\u0103, doza poate varia \u00eentre 150 \u0219i 600 mg pe zi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalina se administreaz\u0103 de obicei cu sau f\u0103r\u0103 alimente. \u00cen cazul dozelor omise, aceasta trebuie luat\u0103 c\u00e2t mai cur\u00e2nd posibil, cu excep\u021bia cazului \u00een care este mai aproape de momentul urm\u0103toarei doze. \u00cen acest caz, doza omis\u0103 trebuie s\u0103rit\u0103, iar programul obi\u0219nuit trebuie continuat.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Efecte secundare \u0219i precau\u021bii<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ca toate medicamentele, pregabalina poate avea efecte secundare. Acestea includ ame\u021beli, somnolen\u021b\u0103, confuzie, dificult\u0103\u021bi de concentrare, vedere \u00eence\u021bo\u0219at\u0103, cre\u0219tere \u00een greutate \u0219i umflarea m\u00e2inilor \u0219i picioarelor. Efecte secundare mai grave includ dureri musculare, sl\u0103biciune, sensibilitate \u0219i modific\u0103ri ale dispozi\u021biei sau comportamentului (cum ar fi sentimente de anxietate sau nelini\u0219te).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pacien\u021bii cu antecedente de abuz de substan\u021be pot avea un risc mai mare de abuz \u0219i dependen\u021b\u0103 atunci c\u00e2nd utilizeaz\u0103 pregabalin\u0103. La pacien\u021bii cu probleme renale existente, este posibil s\u0103 fie necesar\u0103 ajustarea dozei \u0219i trebuie utilizat cu pruden\u021b\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00centreruperea brusc\u0103 a pregabalinei trebuie evitat\u0103, deoarece poate duce la simptome de sevraj, cum ar fi insomnie, grea\u021b\u0103, dureri de cap \u0219i diaree. Se recomand\u0103 o reducere treptat\u0103 a dozei pe o perioad\u0103 de minimum 1 s\u0103pt\u0103m\u00e2n\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Concluzie<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalina este un medicament puternic \u0219i versatil, cu aplica\u021bii \u00een gestionarea mai multor afec\u021biuni neurologice. \u00cen\u021belegerea farmacologiei sale, a indica\u021biilor, a dozelor \u0219i a poten\u021bialelor efecte secundare poate contribui la optimizarea utiliz\u0103rii sale \u00een practica clinic\u0103. La fel ca toate medicamentele, pregabalina trebuie utilizat\u0103 numai sub conducerea \u0219i supravegherea unui profesionist din domeniul s\u0103n\u0103t\u0103\u021bii. Este esen\u021bial s\u0103 ave\u021bi discu\u021bii deschise \u0219i oneste cu furnizorii de asisten\u021b\u0103 medical\u0103 despre utilizarea sa \u0219i despre orice probleme sau preocup\u0103ri poten\u021biale.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pregabalin<\/strong> este un medicament utilizat pentru a trata mai multe afec\u021biuni neurologice, inclusiv convulsii, tulbur\u0103ri de anxietate \u0219i dureri neuropatice. Acesta apar\u021bine clasei de medicamente cunoscute sub numele de <strong>anticonvulsivante<\/strong>, care ac\u021bioneaz\u0103 prin diminuarea activit\u0103\u021bii anormale din creier.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalina este disponibil\u0103 sub form\u0103 de capsule \u0219i se administreaz\u0103 pe cale oral\u0103. Se absoarbe rapid \u00een fluxul sanguin \u0219i are o biodisponibilitate de aproximativ 90%. Medicamentul atinge concentra\u021biile plasmatice maxime \u00een decurs de 1 p\u00e2n\u0103 la 2 ore de la administrare.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Doza recomandat\u0103 de pregabalin\u0103 variaz\u0103 \u00een func\u021bie de afec\u021biunea tratat\u0103. Pentru convulsiile convulsive, doza ini\u021bial\u0103 este de obicei de 75 mg de dou\u0103 ori pe zi, care poate fi crescut\u0103 p\u00e2n\u0103 la 600 mg pe zi, dup\u0103 cum este necesar. Pentru tulbur\u0103rile de anxietate, doza ini\u021bial\u0103 este de obicei de 150mg pe zi, care poate fi crescut\u0103 p\u00e2n\u0103 la 600mg pe zi, dup\u0103 cum este necesar. Pentru durerile neuropatice, doza de \u00eenceput este de obicei de 150mg pe zi, care poate fi crescut\u0103 p\u00e2n\u0103 la 600mg pe zi, dup\u0103 cum este necesar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalina ac\u021bioneaz\u0103 prin legarea la un tip specific de canal de calciu din sistemul nervos central. Aceast\u0103 legare reduce eliberarea anumitor neurotransmi\u021b\u0103tori, inclusiv a glutamatului \u0219i a substan\u021bei P, care sunt implica\u021bi \u00een durere \u0219i anxietate. Prin reducerea eliber\u0103rii acestor neurotransmi\u021b\u0103tori, pregabalina poate ajuta la reducerea simptomelor de convulsii, anxietate \u0219i durere neuropat\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Utilizarea pregabalinei este asociat\u0103 cu mai multe reac\u021bii adverse poten\u021biale, inclusiv ame\u021beli, somnolen\u021b\u0103, edem periferic \u0219i gur\u0103 uscat\u0103. Au fost raportate \u0219i reac\u021bii adverse mai grave, cum ar fi g\u00e2nduri suicidare, reac\u021bii alergice \u0219i angioedem. Pregabalina nu trebuie utilizat\u0103 la pacien\u021bii cu antecedente de hipersensibilitate la medicament sau la oricare dintre componentele sale.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalina are un poten\u021bial relativ sc\u0103zut de abuz \u0219i dependen\u021b\u0103 \u00een compara\u021bie cu alte medicamente utilizate pentru tratarea anxiet\u0103\u021bii \u0219i a durerii. Cu toate acestea, trebuie totu\u0219i utilizat cu pruden\u021b\u0103 la pacien\u021bii cu antecedente de abuz sau dependen\u021b\u0103 de substan\u021be.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cen concluzie, pregabalina este un medicament cu un palmares dovedit \u00een tratamentul convulsiilor, tulbur\u0103rilor de anxietate \u0219i al durerii neuropatice. Mecanismul s\u0103u de ac\u021biune, care implic\u0103 reducerea eliber\u0103rii anumitor neurotransmi\u021b\u0103tori, a fost bine studiat \u0219i \u00een\u021beles. De\u0219i are un poten\u021bial de efecte secundare, este \u00een general bine tolerat \u0219i are un poten\u021bial sc\u0103zut de abuz \u0219i dependen\u021b\u0103. Ca \u00een cazul oric\u0103rui medicament, pregabalina trebuie utilizat\u0103 sub \u00eendrumarea unui profesionist din domeniul s\u0103n\u0103t\u0103\u021bii.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Uniunea European\u0103 <strong>Pregabalin Legal Status in Europe (2025 Overview)<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pregabalin<\/strong> este un <strong>GABA analogue<\/strong> prescribed for:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Neuropathic pain<\/strong><\/li>\n\n\n\n<li><strong>Generalized anxiety disorder<\/strong><\/li>\n\n\n\n<li><strong>Epilepsie<\/strong><\/li>\n\n\n\n<li><strong>Fibromyalgia (off-label in some countries)<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Comercializat sub denumiri precum <strong>Lyrica<\/strong>, <strong>Alzain<\/strong>, sau <strong>Rewisca<\/strong>, Pregabalin is <strong>structurally similar to Gabapentin<\/strong>, but it has <strong>stronger psychoactive effects<\/strong>, faster onset, and <strong>higher abuse potential<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Due to rising misuse (especially in combination with opioids or benzos), <strong>many European countries have reclassified Pregabalin as a controlled substance<\/strong>, \u0219i <strong>most of the rest are actively monitoring it.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">\ud83d\udd12 <strong>Controlled Substance \u2013 Requires Special Prescription<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalin is a <strong>substan\u021b\u0103 controlat\u0103<\/strong> in a growing number of countries due to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sedative and euphoric effects at high doses<\/li>\n\n\n\n<li>Widespread diversion and recreational use<\/li>\n\n\n\n<li>Serious overdose risks when combined with CNS depressants<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Countries where Pregabalin is <strong>officially controlled (2025)<\/strong>:<\/h4>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>\u021aara<\/th><th>Control Status<\/th><\/tr><\/thead><tbody><tr><td>\ud83c\uddec\ud83c\udde7 <strong>Regatul Unit<\/strong><\/td><td><strong>Class C \/ Schedule 3<\/strong> since 2019. Secure prescription, no repeat dispensing.<\/td><\/tr><tr><td>\ud83c\uddee\ud83c\uddea <strong>Irlanda<\/strong><\/td><td>Controlled since 2020 under <strong>Misuse of Drugs Regulations<\/strong>. Secure prescription required.<\/td><\/tr><tr><td>\ud83c\uddf3\ud83c\uddf4 <strong>Norvegia<\/strong><\/td><td>Fully controlled. Requires special prescription.<\/td><\/tr><tr><td>\ud83c\udde8\ud83c\udded <strong>Elve\u021bia<\/strong><\/td><td>Controlled under narcotics law. Dispensing restrictions apply.<\/td><\/tr><tr><td>\ud83c\uddeb\ud83c\uddee <strong>Finlanda<\/strong><\/td><td>Reclassified as a <strong>controlled psychotropic<\/strong> in 2023. Strict prescribing and monitoring.<\/td><\/tr><tr><td>\ud83c\uddf8\ud83c\uddf0 <strong>Slovacia<\/strong><\/td><td>Controlled under national psychotropic list.<\/td><\/tr><tr><td>\ud83c\uddf8\ud83c\uddee <strong>Slovenia<\/strong><\/td><td>Recently controlled due to increasing misuse cases.<\/td><\/tr><tr><td>\ud83c\udde8\ud83c\uddfe <strong>Cyprus<\/strong><\/td><td>Controlled since 2022.<\/td><\/tr><tr><td>\ud83c\udded\ud83c\uddfa <strong>Ungaria<\/strong><\/td><td>Controlled; limited prescription duration and doses.<\/td><\/tr><tr><td>\ud83c\uddf5\ud83c\uddf1 <strong>Polonia<\/strong><\/td><td>Controlled as of 2024. Electronic prescription monitoring in place.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">\u2705 <strong>Prescription-Only (Not Controlled Yet, But Monitored)<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">These countries <strong>do not officially classify Pregabalin as a narcotic or psychotropic<\/strong>, but they apply <strong>tight restrictions<\/strong> \u0219i <strong>abuse monitoring<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\ud83c\uddeb\ud83c\uddf7 France \u2013 Prescription-only; under enhanced surveillance by ANSM<\/li>\n\n\n\n<li>\ud83c\udde9\ud83c\uddea Germany \u2013 Prescription drug; not scheduled, but pharmacies report high misuse concerns<\/li>\n\n\n\n<li>\ud83c\uddee\ud83c\uddf9 Italy \u2013 Prescription-only; pending re-evaluation by AIFA<\/li>\n\n\n\n<li>\ud83c\udde7\ud83c\uddea Belgium \u2013 Not officially controlled, but flagged for potential abuse<\/li>\n\n\n\n<li>\ud83c\uddea\ud83c\uddf8 Spain \u2013 Prescription-only; under close pharmacovigilance<\/li>\n\n\n\n<li>\ud83c\uddf3\ud83c\uddf1 Netherlands \u2013 Prescription-only; not on Opium Act lists yet<\/li>\n\n\n\n<li>\ud83c\udde9\ud83c\uddf0 Denmark \u2013 Monitored; prescription required<\/li>\n\n\n\n<li>\ud83c\uddf8\ud83c\uddea Sweden \u2013 Prescription-only; abuse cases increasing<\/li>\n\n\n\n<li>\ud83c\uddf5\ud83c\uddf9 Portugal \u2013 Prescription-only, but restrictions apply for long-term use<\/li>\n\n\n\n<li>\ud83c\udde6\ud83c\uddf9 Austria \u2013 Prescription-only, under pharmacovigilance<\/li>\n\n\n\n<li>\ud83c\uddf1\ud83c\uddf9 Lithuania \u2013 Prescription-only, monitored<\/li>\n\n\n\n<li>\ud83c\uddea\ud83c\uddea Estonia \u2013 Same as above<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">\u26a0\ufe0f <strong>Import, Possession, and Travel Rules<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Possessing Pregabalin without prescription<\/strong> este <strong>illegal in all European countries<\/strong>, even if it&#8217;s not scheduled.<\/li>\n\n\n\n<li><strong>Importation is generally banned<\/strong> unless pre-approved (e.g., via medical license or documentation).<\/li>\n\n\n\n<li>In <strong>Schengen countries<\/strong>, Pregabalin <strong>requires a Schengen Certificate for Controlled Substances<\/strong> if traveling to a country where it\u2019s classified as a narcotic.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\ud83d\udcdd Certificate guide:<br><a>https:\/\/www.schengenvisainfo.com\/schengen-certificate\/<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">\ud83e\udde0 Comparison with Gabapentin<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Caracteristic\u0103<\/th><th><strong>Pregabalin<\/strong><\/th><th><strong>Gabapentin<\/strong><\/th><\/tr><\/thead><tbody><tr><td>Potency<\/td><td>Mai mare<\/td><td>Lower<\/td><\/tr><tr><td>Debut<\/td><td>Faster (30\u201360 min)<\/td><td>Slower (60\u2013120 min)<\/td><\/tr><tr><td>Control Status<\/td><td>Controlled in 10+ countries<\/td><td>Controlled in ~6 countries<\/td><\/tr><tr><td>Abuse Potential<\/td><td>Mai mare<\/td><td>Moderat<\/td><\/tr><tr><td>Legal Trend<\/td><td>More restrictions added yearly<\/td><td>Slowly rising control<\/td><\/tr><\/tbody><\/table><\/figure>","protected":false},"excerpt":{"rendered":"<p>Pregabalina este un medicament care apar\u021bine clasei de medicamente cunoscute sub numele de anticonvulsivante. Acesta este utilizat \u00een mod obi\u0219nuit pentru a trata durerea nervoas\u0103 cauzat\u0103 de afec\u021biuni precum diabetul, zona zoster sau leziuni ale m\u0103duvei spin\u0103rii. Pregabalina ac\u021bioneaz\u0103 prin reducerea num\u0103rului de semnale de durere trimise de nervii deteriora\u021bi din organism, ajut\u00e2nd astfel la ameliorarea simptomelor durerii nervoase. Este disponibil sub form\u0103 de capsule \u0219i se administreaz\u0103 pe cale oral\u0103, de obicei de dou\u0103 sau trei ori pe zi. Pregabalina poate provoca efecte secundare, cum ar fi ame\u021beli, somnolen\u021b\u0103 \u0219i vedere \u00eence\u021bo\u0219at\u0103, \u0219i trebuie administrat\u0103 numai sub supravegherea unui profesionist din domeniul s\u0103n\u0103t\u0103\u021bii.<\/p>\n<p>Acest produs este livrat din Europa cu num\u0103r de urm\u0103rire.<\/p>\n<p><strong>ATEN\u021aIE<\/strong><\/p>\n<p>\u00cenainte de a plasa o comand\u0103, TREBUIE s\u0103 verifica\u021bi legisla\u021bia actualizat\u0103 din \u021bara dumneavoastr\u0103.<\/p>\n<p>De obicei, pute\u021bi g\u0103si lista substan\u021belor reglementate pe site-ul .gov al \u021b\u0103rii dumneavoastr\u0103. Dac\u0103 comanda\u021bi orice produs controlat \u0219i acesta este confiscat de autorit\u0103\u021bile vamale locale, nu se accept\u0103 reclama\u021bii sau ramburs\u0103ri.<\/p>\n<p>NU SUNTEM RESPONSABILI.<\/p>","protected":false},"featured_media":48515,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[58,62],"product_tag":[513,507,508,506,500,501,502,512,497,504,498,515,503,402,510,499,509,505,511,516,514],"class_list":["post-24372","product","type-product","status-publish","has-post-thumbnail","product_cat-eu-meds","product_cat-painkiller-eu","product_tag-anticonvulsant-medicine","product_tag-anxiety-relief","product_tag-anxiolytic-drug","product_tag-chronic-pain-control","product_tag-epilepsy-treatment","product_tag-fibromyalgia-management","product_tag-gabapentinoid","product_tag-generalized-anxiety-disorder","product_tag-lyrica-drug","product_tag-lyrica-uses","product_tag-nerve-pain-relief","product_tag-neuropathic-pain-treatment","product_tag-neuropathy-therapy","product_tag-pain-management","product_tag-pregabalin-dosage","product_tag-pregabalin-medication","product_tag-pregabalin-safety","product_tag-pregabalin-side-effects","product_tag-prescription-medication","product_tag-sandoz-pregabalin","product_tag-seizure-control","first","outofstock","sale","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"_links":{"self":[{"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product\/24372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/comments?post=24372"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/media\/48515"}],"wp:attachment":[{"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/media?parent=24372"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product_brand?post=24372"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product_cat?post=24372"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product_tag?post=24372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}